De Stefano L, Balduzzi S, Bogliolo L, D'Onofrio B, et al. Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs. Clin Exp Rheumatol 2023;41:667-675.
PMID: 36135948